ALS

Rapid diagnostic test developed for ALS
By LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Nerve Neuron Axon Social
NeuroSense, NeuraLight partner on biomarkers for ALS
By LabPulse.com staff writers
NeuraLight uses proprietary computer vision and learning algorithms to extract coulometric markers from facial videos captured with a webcam. NeuroSense is conducting the phase IIB PARADIGM trial evaluating the efficacy of NeuroSense's lead combination drug candidate, PrimeC, in treating ALS.
July 27, 2022
2022 03 11 19 35 9195 Business Handshake Woman 400
Arlington Scientific, Brain Chemistry Labs ink collaboration
By LabPulse.com staff writers
Only 8% to 10% of ALS cases are genetic, according to Brain Chemistry Labs. In 90% to 92% of cases, environmental risk factors may play a role. BMAA is often present in cyanobacterial blooms in water and is suspected to be the top environmental factor contributing to ALS, the company said.
March 20, 2022
2022 03 21 22 04 1949 Lab Microscope Woman 20220321221938 20220321222023
Page 1 of 1